LAS 152 (Dallergy chlorpheniramine maleate 2 mg / methscopolamine nitrate 1.25 mg / phenylephrine hydrochloride 10 mg)
This pill with imprint "LAS 152" is Purple, Elliptical / Oval and has been identified as Dallergy chlorpheniramine maleate 2 mg / methscopolamine nitrate 1.25 mg / phenylephrine hydrochloride 10 mg. It is manufactured by Palmetto Pharmaceuticals Inc.
Chlorpheniramine/methscopolamine/phenylephrine is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Chlorpheniramine/methscopolamine/phenylephrine chlorpheniramine maleate 2 mg / methscopolamine nitrate 1.25 mg / phenylephrine hydrochloride 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- LAS 152
- chlorpheniramine maleate 2 mg / methscopolamine nitrate 1.25 mg / phenylephrine hydrochloride 10 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Palmetto Pharmaceuticals Inc
More about chlorpheniramine/methscopolamine/phenylephrine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
- Chlorpheniramine/methscopolamine/phenylephrine suspension
- Chlorpheniramine/phenylephrine/methscopolamine chewable tablets
- Chlorpheniramine/phenylephrine/methscopolamine controlled-release tablets
- Chlorpheniramine/phenylephrine/methscopolamine sustained-release and long-acting tablets
- More... (3)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.